SEC Form 4 · accession 0001104659-16-112547
Verastem, Inc. · VSTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Berk
Officer — Chief Medical Officer
Period of report
Apr 15, 2016
Accepted (ET)
Apr 19, 2016 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001526119
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.51 | Apr 15, 2016 | A | 370,000 | A | — | Apr 15, 2026 | Common Stock | 370,000 | 370,000 | D |
Explanation of responses
- F125% of this option will vest on April 15, 2017 and then in equal three-month installments until April 15, 2020